GL1X · GenesisL1 explorer

Research workbench

Dimeric 6-phosphogluconate dehydrogenase complexed with 6- phosphogluconate

Analyse Dimeric 6-phosphogluconate dehydrogenase complexed with 6- phosphogluconate in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ZYA
Type
protein
Length
931 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
6-phosphogluconate dehydrogenase, decarboxylating
EC
1.1.1.44
UniProt
P00350
Ligands
6PG
Pockets
8 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 58% helix, 10% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)protein46558% helix, 10% strandP00350
B6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)protein46658% helix, 11% strandP00350

Ligands and binding sites

  • 6PG · 6-phosphogluconic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11510.820.9851empty
24020.710.82466PG
34260.700.81496PG
42150.510.7627empty
51850.470.7625empty

Interfaces

1 interface between chains.

  • A–B · 5491 Ų buried · 56 hydrogen bonds · protein-protein

Compared structures

  • 2ZYA · Dimeric 6-phosphogluconate dehydrogenase complexed with 6-phosphogluconate · the same entry in another collection · chain A against A, TM-score 1.00
  • P00350 · AlphaFold monomer V2.0 prediction for 6-phosphogluconate dehydrogenase, decarboxylating… · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.